Lisata Therapeutics, Inc. (LSTA) Financials
LSTA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 14.1 million | 3.4 million |
| Dec. 31, 2025 | 17.7 million | 3.1 million |
| Sept. 30, 2025 | 21.8 million | 4.6 million |
| June 30, 2025 | 25.2 million | 4.4 million |
LSTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.1 million | 364000 |
| Dec. 31, 2025 | -3.2 million | 225000 |
| Sept. 30, 2025 | -3.3 million | 232000 |
| June 30, 2025 | -4.0 million | 239000 |
LSTA Net Income
No data available :(
LSTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 13.1 million | - | - |
| Dec. 31, 2025 | 16.0 million | - | - |
| Sept. 30, 2025 | 19.0 million | - | - |
| June 30, 2025 | 22.0 million | - | 47000 |
LSTA Shares Outstanding
LSTA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.2 million | 3.7 million | - |
| Dec. 31, 2025 | - | 1.1 million | 2.0 million | - |
| Sept. 30, 2025 | - | 2.0 million | 2.5 million | - |
| June 30, 2025 | 28000 | 2.3 million | 2.7 million | - |
LSTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 2000 |
| Dec. 31, 2025 | 100000 | 15000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | 70000 | 44000 |
LSTA
Price: $1.55
52 week price:
Dividend Yield: 29.81%
Earnings Per Share: -1.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.5 million